Adolescents’ Reward-related Neural Activation: Links to Thoughts of Nonsuicidal Self-Injury

od Poon, Jennifer A., Thompson, James C., Forbes, Erika E., Chaplin, Tara M.
Wydane w Suicide Life Threat Behav (2018)

Adolescents' pubertal development: Links between testosterone, estradiol, and neural reward processing

od Poon, Jennifer A., Niehaus, Claire E., Thompson, James C., Chaplin, Tara M.
Wydane w Horm Behav (2019)

Adolescent Substance Use & Psychopathology: Interactive Effects of Cortisol Reactivity and Emotion Regulation

od Poon, Jennifer A., Turpyn, Caitlin C., Hansen, Amysue, Jacangelo, Juliana, Chaplin, Tara M.
Wydane w Cognit Ther Res (2015)

Associations Between Parent Emotional Arousal and Regulation and Adolescents’ Affective Brain Response

od Turpyn, Caitlin C., Poon, Jennifer A., Ross, Corynne E., Thompson, James C., Chaplin, Tara M.
Wydane w Soc Dev (2017)

Sex-Differentiated Associations among Negative Parenting, Emotion-Related Brain Function, and Adolescent Substance Use and Psychopathology Symptoms

od Chaplin, Tara M., Poon, Jennifer A., Thompson, James C., Hansen, Amysue, Dziura, Sarah L., Turpyn, Caitlin C., Niehaus, Claire E., Sinha, Rajita, Chassin, Laurie, Ansell, Emily B.
Wydane w Soc Dev (2019)

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias

od Gojo, Ivana, Sadowska, Mariola, Walker, Alison, Feldman, Eric J., Iyer, Swaminathan Padmanabhan, Baer, Maria R., Sausville, Edward A., Lapidus, Rena G., Zhang, Da, Zhu, Yali, Jou, Ying-Ming, Poon, Jennifer, Small, Karen, Bannerji, Rajat
Wydane 2013

Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

od Fangusaro, Jason, Cefalo, Maria Giuseppina, Garré, Maria Luisa, Marshall, Lynley V., Massimino, Maura, Benettaib, Bouchra, Biserna, Noha, Poon, Jennifer, Quan, Jackie, Conlin, Erin, Lewandowski, John, Simcock, Mathew, Jeste, Neelum, Hargrave, Darren R., Doz, François, Warren, Katherine E.
Wydane w Front Oncol (2021)

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies

od Mita, Monica M, Mita, Alain C, Moseley, Jennifer L, Poon, Jennifer, Small, Karen A, Jou, Ying-Ming, Kirschmeier, Paul, Zhang, Da, Zhu, Yali, Statkevich, Paul, Sankhala, Kamelesh K, Sarantopoulos, John, Cleary, James M, Chirieac, Lucian R, Rodig, Scott J, Bannerji, Rajat, Shapiro, Geoffrey I
Wydane w Br J Cancer (2017)